J2175 Insurance Policy Changes

HCPCS J2175 is officially defined as "Injection, meperidine hydrochloride, per 100 mg." HCPCS J2175 is referenced in 4 tracked payer policy changes from Blue Cross and Blue Shield of Kansas City and Humana. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS J2175 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.